| Title : Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate - Haroldsen_2015_Pharmacol.Res.Perspect_3_e00099 |
| Author(s) : Haroldsen PE , Garovoy MR , Musson DG , Zhou H , Tsuruda L , Hanson B , O'Neill CA |
| Ref : Pharmacol Res Perspect , 3 :e00099 , 2015 |
| Abstract : Haroldsen_2015_Pharmacol.Res.Perspect_3_e00099 |
| ESTHER : Haroldsen_2015_Pharmacol.Res.Perspect_3_e00099 |
| PubMedSearch : Haroldsen_2015_Pharmacol.Res.Perspect_3_e00099 |
| PubMedID: 25692017 |
Haroldsen PE, Garovoy MR, Musson DG, Zhou H, Tsuruda L, Hanson B, O'Neill CA (2015)
Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate
Pharmacol Res Perspect
3 :e00099
Haroldsen PE, Garovoy MR, Musson DG, Zhou H, Tsuruda L, Hanson B, O'Neill CA (2015)
Pharmacol Res Perspect
3 :e00099